保守透析策略与透析依赖型急性肾损伤的肾功能恢复:LIBERATE-D随机临床试验
这项多中心、非盲、优效性随机试验在美国4个临床中心纳入221例透析依赖型急性肾损伤患者(基线eGFR>15 mL/min/1.73 m2、已启动肾脏替代治疗、血流动力学稳定、计划间歇性血液透析),随机分配至保守透析策略(仅在满足特定代谢或临床指征时透析)或常规透析策略(每周3次直至达到尿量或肌酐清除率标准)。主要终点为出院时未调整的肾功能恢复(存活、未透析且连续至少14天无透析)。保守组64%(70/109)达到主要终点,常规组50%(55/109),差异13.8%(95%CI 0.8%-26.8%;P=.04),未调整OR 1.76(95%CI 1.02-3.03;P=.04),预设调整后OR 1.56(95%CI 0.86-2.84;P=.15)。保守组每周透析次数更少(中位1.8 vs 3.1次;差异-1.4,95%CI -1.8至-1.0),至第28天连续无透析天数更多(中位21 vs 5天;差异16天,95%CI 5-27),透析相关低血压事件更少(69 vs 97次)。作者结论认为保守策略在未调整分析中带来更短恢复时间和更高恢复率,鉴于效应量估计的不确定性,该方法应在更大研究人群中验证。
要点
- 血流动力学稳定的透析依赖型急性肾损伤患者,保守透析策略(仅按指征透析)出院时肾功能恢复率64% vs 常规每周3次透析50%,未调整差异13.8%(95%CI 0.8%-26.8%;P=.04)。
- 预设调整后OR 1.56(95%CI 0.86-2.84;P=.15),未达统计学显著,作者认为效应量存在不确定性。
- 保守组每周透析次数中位1.8次 vs 常规组3.1次(差异-1.4,95%CI -1.8至-1.0),至第28天连续无透析天数中位21天 vs 5天(差异16天,95%CI 5-27)。
- 透析相关低血压事件保守组69次 vs 常规组97次。
- 作者结论:保守透析策略在未调整分析中带来更短恢复时间和更高恢复率,但应在更大研究人群中进一步验证。
适用人群与场景
- 纳入标准:透析依赖型急性肾损伤、基线估算肾小球滤过率大于15 mL/min/1.73 m2、已启动肾脏替代治疗、血流动力学稳定、计划间歇性血液透析的患者。
- 研究在美国4个临床中心进行,随机化时间为2020年1月23日至2025年3月10日,末次随访日期为2025年6月10日。
- 共评估909例患者资格,221例随机化,220例接受分配干预。
处置流程与药物剂量
- 保守透析策略:仅在满足特定代谢或临床指征时进行透析。
- 常规透析策略:每周透析3次,直至达到尿量或肌酐清除率标准。
研究设计与关键结果
- 研究类型:多中心、非盲、优效性随机临床试验(LIBERATE-D),美国4个临床中心,221例随机化、220例接受干预。
- 人群特征:平均年龄56岁(SD 16岁);148/220(67%)为男性,28例(13%)为黑人,133例(60%)为白人;平均基线eGFR 64.8 mL/min/1.73 m2(SD 30.9);随机化前启动肾脏替代治疗中位时间9天(IQR 5-18.5天)。
- 主要终点(出院时未调整肾功能恢复):保守组70/109(64%)vs 常规组55/109(50%),差异13.8%(95%CI 0.8%-26.8%;P=.04);未调整OR 1.76(95%CI 1.02-3.03;P=.04);预设调整后OR 1.56(95%CI 0.86-2.84;P=.15)。
- 关键次要终点:每周透析次数中位1.8次(IQR 0-2.6)vs 3.1次(IQR 2.6-3.5),差异-1.4(95%CI -1.8至-1.0);至第28天连续无透析天数中位21天(IQR 0-28)vs 5天(IQR 0-21),差异16天(95%CI 5-27)。
- 不良事件:透析相关低血压事件保守组69次 vs 常规组97次。
证据类型、等级与局限
- 证据类型:多中心、非盲、优效性随机临床试验。
- 作者结论指出,鉴于效应量估计的不确定性,该方法应在更大研究人群中验证。
对床旁实践的改变
- 对于血流动力学稳定、已启动肾脏替代治疗且计划间歇性血液透析的透析依赖型急性肾损伤患者,保守透析策略(仅按特定代谢或临床指征透析)在未调整分析中与更高的出院时肾功能恢复率和更短的恢复时间相关。
- 保守透析策略可减少每周透析次数并增加至第28天的连续无透析天数,且透析相关低血压事件更少。
- 作者认为,鉴于效应量估计的不确定性,该策略应在更大研究人群中进一步验证。
指南或共识出处
- LIBERATE-D随机临床试验(ClinicalTrials.gov标识符:NCT04218370)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: For patients with dialysis-requiring acute kidney injury, persistent need for dialysis is associated with increased morbidity and mortality, high health care use, and poor quality of life.
OBJECTIVE: To test the effect of a conservative dialysis strategy on recovery of kidney function.
DESIGN, SETTING, AND PARTICIPANTS: This multicenter, unblinded, randomized superiority trial enrolled participants with dialysis-requiring acute kidney injury who had a baseline estimated glomerular filtration rate greater than 15 mL/min/1.73 m2, had already initiated kidney replacement therapy, and were hemodynamically stable, with planned intermittent hemodialysis between January 23, 2020, and March 10, 2025, at 4 clinical sites in the United States. Of 909 patients assessed for eligibility, 221 were randomized and 220 received the allocated intervention. The date of last follow-up was June 10, 2025.
INTERVENTION: With the conservative dialysis strategy, participants received dialysis only when specific metabolic or clinical indications were met. Participants in the conventional dialysis group received dialysis 3 times per week until urine output or creatinine clearance criteria were met.
MAIN OUTCOMES AND MEASURES: The primary study end point was unadjusted kidney function recovery at hospital discharge, defined as being alive and not receiving dialysis, with at least 14 consecutive days without dialysis (including after discharge). Two prespecified key secondary end points were the number of dialysis sessions per week and the number of dialysis-free days to day 28.
RESULTS: The mean age of participants was 56 years (SD, 16 years). A total of 148 of 220 participants (67%) were male, 28 (13%) were Black, and 133 (60%) were White. Mean baseline estimated glomerular filtration rate was 64.8 mL/min/1.73 m2 (SD, 30.9 mL/min/1.73 m2). Participants had started kidney replacement therapy a median of 9 days (IQR, 5-18.5 days) before randomization. In the conservative dialysis intervention group, 70 of 109 participants (64%) achieved kidney function recovery at hospital discharge vs 55 of 109 participants (50%) in the conventional dialysis control group (difference, 13.8% [95% CI, 0.8%-26.8%; P = .04]; unadjusted odds ratio, 1.76 [95% CI, 1.02-3.03; P = .04]; after prespecified adjustment: odds ratio, 1.56 [95% CI, 0.86-2.84; P = .15]). Participants in the conservative dialysis group received fewer dialysis sessions per week (median, 1.8 [IQR, 0-2.6] vs 3.1 [IQR, 2.6-3.5]; difference, -1.4 [95% CI, -1.8 to -1.0]) and recovered earlier (21 [IQR, 0-28] vs 5 [IQR, 0-21] consecutive dialysis-free days to day 28; difference, 16 days [95% CI, 5-27]). Dialysis-associated hypotension occurred less frequently in the conservative dialysis group (69 vs 97 events).
CONCLUSIONS AND RELEVANCE: A conservative dialysis strategy in dialysis-requiring acute kidney injury resulted in a shorter time to and higher rates of recovery of kidney function in the unadjusted analysis. Given uncertainty regarding the estimated effect size, this approach should be tested in a larger study population.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04218370.
参考来源
- Liu KD, Siew ED, Tuot DS, et al. A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial. JAMA. 2026. PMID: 41201895. doi:10.1001/jama.2025.21530
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。